IO THERAPEUTICS
Io Therapeutics, Inc. was founded to develop and commercialize a series of retinoid and rexinoid compounds originally discovered at Allergan, Inc. by Rosh Chandraratna, one of Io Therapeutics’ founders.
IO THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2010-01-01
Address:
Santa Ana, California, United States
Country:
United States
Website Url:
http://www.io-therapeutics.com
Total Employee:
1+
Status:
Active
Contact:
6503422167
Email Addresses:
[email protected]
Total Funding:
443.5 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx Google Maps
Similar Organizations
Affini-T Therapeutics
Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.
Capstone Therapeutics
Capstone Therapeutics biotechnology company committed to developing a pipeline of novel peptides and other molecules.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Compound Focus
Compound Focus, Inc. offers molecule compound management services for liquid and solid compounds.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Forge Therapeutics
Forge Therapeutics is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
NovelMed Therapeutics
NovelMed Therapeutics is a biotechnology company developing novel therapies for orphan and non-orphan diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Employees Featured
Founder
Official Site Inspections
http://www.io-therapeutics.com
- Host name: mail.sparkle123.com
- IP address: 162.144.12.144
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Io Therapeutics"
- Io Therapeutics, Inc.
Io Therapeutics, Inc. is a privately held biopharmaceutical company headquartered in Houston, Texas. The company’s mission is to discover and develop therapeutic compounds targeting …See details»
Io Therapeutics - Crunchbase Company Profile & Funding
Io Therapeutics, Inc. is a biopharmaceutical company based in Houston, Texas, operating privately. Its primary objective involves the exploration and …See details»
IO Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for IO Therapeutics, Inc. of Spring, TX. Get the latest business insights from Dun & Bradstreet.See details»
About - Io Therapeutics, Inc.
Immuno-oncology Autoimmune Therapeutics Neurotherapeutics. Skip to content Toggle Navigation. Home; About. Overview; Board and Management; Advisors; ContactSee details»
Home - IO Biotech
During his career, he chaired the EORTC (European Organization for Research and Treatment of Cancer) from 2003 to 2006 and ECCO (European CanCer Organization) from 2008 to 2010. …See details»
Board and Management - Io Therapeutics, Inc.
Dr. Sanders is a co-founder of Io Therapeutics. He serves as Executive Chairman of the Io Therapeutics Board of Directors and as Chief Executive Officer of the company. ... In 2019, …See details»
Io Therapeutics - Overview, News & Similar companies - ZoomInfo
Io Therapeutics is a privately owned, clinical stage biopharmaceutical company that is advancing the development and commercialization of three tar geted, clinical stage small molecule …See details»
Io Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials
Explore Io Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 5 clinical trials, 3 news, and 6 literature, Disease Domain:Neoplasms ...See details»
Io Therapeutics | Biotech Careers
Io Therapeutics, Inc. is a privately held biopharmaceutical company headquartered in Houston, Texas. The company’s mission is to discover and develop therapeutic compounds targeting …See details»
IO THERAPEUTICS, INC. - VentureRadar
Io Therapeutics is discovering and developing a series of retinoid and rexinoid small molecules for the treatment of cancers, neurodegenerative diseases, and autoimmune diseases. The …See details»
Io Therapeutics Company Profile - Office Locations, Competitors
Io Therapeutics Summary. Company Summary. Overview. Io Therapeutics is a biopharmaceutical company developing and commercializing a series of retinoid and rexinoid compounds. It …See details»
Io Therapeutics - Contacts, Employees, Board Members
Io Therapeutics is a biotechnology company developing a series of retinoid and rexinoid compounds. New. Resources. Advanced Search. Start Free Trial ... Experience the new …See details»
Io Therapeutics, Inc. - BIO International Convention | BIO
Jun 5, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Io …See details»
Io Therapeutics-Io Therapeutics, Inc.-企业详情-InvestGO数据库 …
Dec 31, 2009 查看医药魔方InvestGO®数据库Io Therapeutics的公司信息。Io Therapeutics（Io Therapeutics, Inc.），公司简介：Io Therapeutics, Inc. was founded to develop and …See details»
Io Therapeutics, Inc., announces presentation of data on
Nov 8, 2024 Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor …See details»
IRX-4204 by Io Therapeutics for Parkinson's Disease: Likelihood of …
Dec 30, 2024 Io Therapeutics is headquartered in Santa Ana, California, the US. For a complete picture of IRX-4204’s drug-specific PTSR and LoA scores, buy the report here. Data Insights. …See details»
Overview - Io Therapeutics, Inc.
Io Therapeutics is discovering and developing a series of retinoid and rexinoid small molecules for the treatment of cancers, neurodegenerative diseases, and autoimmune diseases. The …See details»
Martin Sanders - BIO International Convention | BIO
Dr. Sanders is President and Chief Executive Officer of Io Therapeutics. He is a graduate of the University of Chicago Pritzker School of Medicine, did internship and Residency in Internal …See details»
Pipeline - Io Therapeutics, Inc.
Immuno-oncology Autoimmune Therapeutics Neurotherapeutics. Skip to content Toggle Navigation. Home; About. Overview; Board and Management; Advisors; ContactSee details»
Pharmaceutical Manufacturer Assertio Therapeutics Inc. Agrees to …
3 hours ago The Justice Department announced today that Assertio Therapeutics Inc., formerly known as Depomed Inc., (Assertio), a pharmaceutical company headquartered in Lake Forest, …See details»